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The Portuguese version of the Clinical Global
Impression – Schizophrenia Scale: validation study
Versão em português da Impressão Clínica Global -
Escala de Esquizofrenia: estudo de validação
Abst rac t
Objectives: The Clinical Global Impression – Schizophrenia Scale was designed to assess severity and treatment response in
subjects with schizophrenia involved in naturalistic studies and daily clinical practice. The objective of this study is to validate the
Portuguese version of the Clinical Global Impression – Schizophrenia Scale in Brazil by assessing its psychometric properties.
Method: Cross-sectional validation study of the Portuguese version of the Clinical Global Impression – Schizophrenia Scale,
tested in outpatients and inpatients with schizophrenia (DSM-IV, ICD-10) from 6 centers in Brazil. Concurrent validity and
sensitivity to change were assessed by comparison with the Positive and Negative Syndrome Scale, which is considered the gold
standard tool to evaluate patients with schizophrenia. Interrater reliability was evaluated by intraclass correlation coefficients (ICC)
calculated based on the scoring of two concomitant raters. Results: 70 inpatients and 70 outpatients were evaluated. Total
Clinical Global Impression – Schizophrenia Scale and Positive and Negative Syndrome Scale scores were highly correlated
(r = 0.79; p < 0.01). Positive (r = 0.86), negative (r = 0.79), depressive (r = 0.66) and cognitive (r = 0.75) symptoms subscale
scores were also correlated between both scales (p < 0.01). Sensitivity to change was significantly correlated between the Clinical
Global Impression – Schizophrenia Scale and Positive and Negative Syndrome Scale (r = 0.73; p < 0.01). Interrater reliability
was substantial for positive symptoms and total scores of the Clinical Global Impression – Schizophrenia Scale (ICC = 0.81 and
0.73), and moderate for negative, depressive, and cognitive symptoms score (0.64, 0.67 and 0.63, respectively). Conclusions:
The Brazilian version of the Clinical Global Impression – Schizophrenia Scale is a valid and reliable instrument for the assessment
of severity and treatment response in schizophrenic inpatient and outpatients.
Descriptors: Schizophrenia; Psychiatric status rating scales; Validity of tests; Validation studies; Multicenter study
Resumo
Objetivos: A Escala de Impressão Clínica Global – Esquizofrenia é um instrumento de aplicação simples e rápido, utilizado para
avaliar a severidade de sintomas em pacientes com esquizofrenia. Pode ser aplicado em estudos naturalísticos e na prática
clínica. O objetivo deste trabalho é estudar as propriedades psicométricas e validar a versão Brasileira da Escala de Impressão
Clínica Global – Esquizofrenia em nosso meio. Método: Estudo transversal de validação da Escala de Impressão Clínica Global –
Esquizofrenia, na versão em Português, em pacientes com esquizofrenia, hospitalizados e em tratamento ambulatorial (DSM-IV,
ICD-10), selecionados em seis centros no Brasil. Validade concorrente e sensibilidade à mudança foram determinadas em
comparação com a escala Positive and Negative Syndrome Scale, considerada padrão-ouro. Confiabilidade interavaliador foi
determinada através de coeficientes de correlação intraclasse (ICC), calculados a partir das pontuações de dois avaliadores
concomitantemente. Resultados: Setenta pacientes hospitalizados e 70 em tratamento ambulatorial foram incluídos. Os coefi-
cientes de correlação de Pearson entre Escala de Impressão Clínica Global – Esquizofrenia e Positive and Negative Syndrome Scale
foram: pontuação total (0,79), sintomas positivos (r = 0,86), negativos (r = 0,79), depressivos (r = 0,66) e cognitivos (r = 0,75,
todos com p < 0,01). A confiabilidade interavaliadores da Escala de Impressão Clínica Global – Esquizofrenia foi alta para
sintomas positivos e pontuação total; e moderada para sintomas negativos, depressivos e cognitivos. A sensibilidade ao grau de
mudança foi moderadamente e significativamente correlacionada entre as duas escalas (r = 0,73, p < 0,01). Conclusões: A
Escala de Impressão Clínica Global – Esquizofrenia em Português é um instrumento de boa validade e confiabilidade na avaliação
da evolução de pacientes com esquizofrenia no Brasil, tanto em tratamento ambulatorial como hospitalizados.
Descritores: Esquizofrenia: Escalas de Graduação psiquiátrica; Validade dos testes; Estudos de validação; Estudo multicêntrico
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Int roduct ion
The quantification of schizophrenia psychopathology requires
multidimensional instruments capable of assessing its main clinical
features, not only positive and negative symptoms,1  but also other
important dimensions commonly present in these patients.2  Three
instruments translated and validated for use in Brazilian
populations of schizophrenic patients, the Positive and Negative
Syndrome Scale (PANSS),3,4 the Brief Psychiatric Rating Scale
(BPRS),5,6 and the Calgary Depression Rating Scale for
Schizophrenia (CDRS)7 were developed for research purposes;
being extensive and time-consuming (typically more than 30 min).
The Clinical Global Impression scale (CGI) is a concise
instrument that has been used in studies of treatment response
in schizophrenia, but it lacks specificity on psychosis and
schizophrenia. In order to fill this gap, Haro et al. created the
Clinical Global Impression - Schizophrenia Scale (CGI-SCH),8
a brief instrument adapted from the CGI scale9 and the CGI -
Bipolar Version (CGI-BP) scale.10 The CGI-SCH was developed
for use in the Schizophrenia Outpatient Health Outcomes
(SOHO) Study,11 an observational study of the outcomes of
antipsychotic treatment in schizophrenia.
The CGI-SCH has two categories: severity of illness (CGI-SCH
SI) and degree of change (CGI-SCH DC). The severity of illness
evaluates the clinical situation during the week previous to the
assessment, while the degree of change category evaluates the
change of the severity of the disorder between two time-points.
Each category contains five different ratings that evaluate
positive, negative, depressive, cognitive and global symptoms,
and a seven-point ordinal scale is applied to evaluate these
categories. A short definition of each symptom’s group is included
in the instrument. Ratings of the CGI-SCH are related to the
PANSS dimensions, but the term “SCH cognitive symptoms” is
used instead of “SCH cognitive/disorganization”.
Many psychiatrists face problems when using rating scales
that are not translated and validated into Por tuguese,
particularly in clinical practice contexts. Thus, it would be
very important to offer a simple, easy to administer, and accurate
scale to evaluate patients with schizophrenia in Brazil. In the
present study, a Por tuguese version of the CGI-SCH was
developed and validated for use in Brazilian schizophrenic
patients. Its concurrent validity, interrater reliability and
sensitivity to change were analyzed.
Method
This is an observational, longitudinal, naturalistic, multi-
centric study for patients with schizophrenia. The original CGI-
SCH English version was translated to Brazilian Portuguese
using standard translation/back translation procedures after
discussion with an expert panel (Appendix 1).
Individuals with diagnosis of schizophrenia, according to DSM-
IV criteria, receiving psychiatric treatment either as inpatients or
outpatients, both genders, and who were at least 18 years old
were included in this study. Consecutive patients meeting inclusion
criteria by clinical interview in each site were included in the
study. Those subjects who refused to participate in the study
were excluded. For inpatients, the first evaluation should be
performed within 7 days after admission. All participants provided
a written authorization to release information. Interviewers were
trained in the use of the PANSS by a certified trainer.
Outpatients were evaluated in only one occasion by two
psychiatrists. One of the psychiatrists conducted the interview and
completed the three instruments (socio-demographic and clinical
questionnaire, the CGI-SCH SI, and the PANSS) independently.
For inpatients, the first evaluation was similar to the
outpatients’ one. The second evaluation was done exclusively
by one psychiatrist at discharge (or at 30 days from admission),
and included the same instruments, except that CGI-SCH
severity of illness and degree of change were rated. The order
of administration, considering the complexity of scales, was
the following: socio-demographic and clinical questionnaire,
CGI-SCH, and PANSS.
For CGI-SCH analysis, concurrent validity was assessed by
analyzing the agreement between CGI-SCH and PANSS ratings.
Pearson correlation coefficients were used for statistical
association, and considered significant when p < 0.05.
Interrater reliability was assessed by comparing the ratings
of each of the CGI-SCH dimensions administered by two
psychiatrists to the same patient, and analyzed using intraclass
correlation coefficients (ICC).12 ICC values range from 0 to 1,
values of 0.7 and over indicate ‘substantial agreement’ and
values of 0.5-0.7 indicate ‘moderate agreement’.13
Sensitivity to change was evaluated by comparing the changes
in the domains of the CGI-SCH (severity of illness and degree of
change) and the PANSS from admission to discharge or 30
days after the first evaluation. Pearson correlation coefficients
were calculated based on scores of both scales
Resu l t s
One hundred and forty patients were included in the study,
70 inpatients and 70 outpatients. The second evaluation was
not carried out for 4 subjects (5.7%) because of loss of follow-
up. Centers were from two States of the country (Minas Gerais
and Rio Grande do Sul): Casa de Saúde Santa Maria (29.3%
of included subjects), Instituto de Previdência dos Servidores
do Estado de Minas Gerais (23.6%), Hospital Espírita de Porto
Alegre (16.4%), Ambulatório da Faculdade de Medicina da Uni-
versidade Federal de Pelotas (10%), and Hospital Psiquiátrico
São Pedro in Porto Alegre (8.6%). Most of patients were males
(62%), unemployed (47.9%), with a mean PANSS total score
of 81.2 (SD 25.2) in the first evaluation.
Comorbidity with drug and alcohol abuse/dependence affected
7.1% and 5.7% of the sample, respectively. For inpatients,
mean length of hospital stay was 23.5 days (SD 8.2), and
only 42.9% were still in hospital for the second evaluation.
The most prescribed drugs during hospitalization included
antipsychotics (92.9%), anxiolytics/sedatives (51.4%),
anticholinergics (45.7%), and mood stabilizers (32.9%).
Intraclass correlation coefficients (ICC) were statistically
significant for each domain of the instruments. For the CGI-SCH,
substantial agreement was found for positive symptoms (0.81)
and total score (0.73). For negative (0.64), depressive (0.67),
and cognitive symptoms (0.63), interrater reliability was
moderate. For the PANSS, interrater reliability was substantial
for all domains, ranging from 0.77 to 0.89.
Regarding correlation between scales, it was moderate for
positive, negative, cognitive and total score domains (0.86,
0.79, 0.75 and 0.79, respectively) and low for the depressive
domain (0.66). All correlations were statistically significant,
as presented in Table 1. For this analysis, every administration
of the scales were considered, so the sample is not the number
of patients but the number of administrations (n = 342).
Sensitivity to change was evaluated by comparing the
change in scores of the CGI-SCH SI and PANSS. CGI-SCH SI
scores decreased from 4.29 (SD 1.19) in visit 1 to 3.20
(1.28) in visit 2, while PANSS scores changed from 81.25
(SD 25.28) to 64.03 (23.45). CGI-SCH sensitivity to change
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was also evaluated applying Pearson correlation coefficient on
the change in scores of the CGI-SCH SI and PANSS, being
moderate on positive, negative and total scores (0.79, 0.78
and 0.72, respectively), and modest for depressive and cognitive
domains (0.55 and 0.64). All correlations were statistically
significant. A subanalysis comparing interviewers and visits was
consistent with the analysis including all evaluations in the
same sample (p < 0.01 in all groups).
CGI-SCH degree of change was also compared to CGI-SCH SI
and PANSS scores at discharge. These comparisons indicated a
poor sensitivity of the instrument, with low correlation rates as
measured by Pearson coefficients: from 0.5 (negative symptoms)
to 0.7 (positive symptoms) in comparison to the CGI-SCH SI, and
from 0.4 (depressive symptoms) to 0.6 (positive symptoms) in
comparison to the PANSS.
Discuss ion
The CGI-SCH scale is a short instrument for evaluation of the
distinct domains of schizophrenia, easy to administer and not
time-consuming (1-2 minutes to fill in), which can be used
either in clinical or research settings. No specific training is
essential for its administration because the items to be addressed
are simple and the ranking of patients’ symptoms is based on
clinical judgment. This could be a limitation between different
evaluators with distinct clinical experience, but in this study,
with psychiatrists from different backgrounds and settings,
interrater reliability was substantial for total score and positive
symptoms domain. In the negative and cognitive domains of the
scale, where symptoms may be less specific, this is even more
critical. Application of the CGI-SCH by professionals other than
psychiatrists is possibly limited, and should not be considered
for individuals without clinical psychiatric experience.
Overall, the psychometric properties of the CGI-SCH were
good in this study, with a high concurrent validity and an
accurate sensitivity to change, in comparison to PANSS scores.
When compared to the study of development and validation of
the CGI-SCH, by Haro et al.,9 the accuracy of the Brazilian
version was very similar. Total score of the CGI-SCH SI Brazilian
version had a higher concurrent validity, with correlation
coefficients of 0.75 for the original version and 0.79 for the
Brazilian. Sensitivity to change was also comparable between
the Brazilian and the original versions of the CGI-SCH. Similarly
to the original version of the CGI-SCH in English, the degree
of change subscale has a poorer sensitivity to change in
comparison to the CGI-SCH SI, which should be, for this
reason, preferred to evaluate response to treatment and
evolution of the disease.
This study suggests that the CGI-SCH is a simple and
practical instrument that may be applied in Brazil, with
similar properties to more complex and time-consuming
scales such as the PANSS.
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